PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells

Journal of Cellular Biochemistry
Vladimir S ShavvaSergey V Orlov

Abstract

Apolipoprotein A-I (ApoA-I) is the main anti-atherogenic component of human high-density lipoproteins (HDL). ApoA-I gene expression is regulated by several nuclear receptors, which are the sensors for metabolic changes during development of cardiovascular diseases. Activation of nuclear receptor PPARγ has been shown to impact lipid metabolism as well as inflammation. Here, we have shown that synthetic PPARγ agonist GW1929 decreases both ApoA-I mRNA and protein levels in HepG2 cells and the effect of GW1929 on apoA-I gene transcription depends on PPARγ. PPARγ binds to the sites A and C within the hepatic enhancer of apoA-I gene and the negative regulation of apoA-I gene transcription by PPARγ appears to be realized via the site C (-134 to -119). Ligand activation of PPARγ leads to an increase of LXRβ and a decrease of PPARα binding to the apoA-I gene hepatic enhancer in HepG2 cells. GW1929 abolishes the TNFα-mediated decrease of ApoA-I mRNA expression in both HepG2 and Caco-2 cells but does not block TNFα-mediated inhibition of ApoA-I protein secretion by HepG2 cells. These data demonstrate that complex of PPARγ with GW1929 is a negative regulator involved in the control of ApoA-I expression and secretion in human hepatocyte- an...Continue Reading

References

Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J P McVicarJ P Kane
May 15, 1994·Genes & Development·P TontonozB M Spiegelman
Nov 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R M EpandG M Anantharamaiah
Apr 15, 1996·Genes & Development·R P BrunB M Spiegelman
Apr 1, 1996·Current Opinion in Lipidology·P J Barter, K A Rye
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S A KliewerJ M Lehmann
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D S StrausC K Glass
Aug 15, 2000·Molecular and Cellular Biochemistry·R A Srivastava, N Srivastava
Nov 30, 2000·Biochemical and Biophysical Research Communications·J SakamotoH Sawada
Jun 8, 2001·The Journal of Clinical Investigation·G MartinB Staels
Oct 24, 2003·Biochimica Et Biophysica Acta·Michael J HaasArshag D Mooradian
Apr 3, 2004·Journal of Lipid Research·Mohamad NavabAlan M Fogelman
Jun 26, 2004·Molecular Endocrinology·Philippe DeleriveBryan Goodwin
Jun 25, 2005·Circulation Research·Gary F Lewis, Daniel J Rader
Nov 6, 2007·Trends in Immunology·Daniel S Straus, Christopher K Glass
Mar 9, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Ester VanniGianluca Svegliati-Baroni
Jul 6, 2010·Biochemical and Biophysical Research Communications·Sergey V OrlovAndrej P Perevozchikov
Oct 19, 2010·Biochemical and Biophysical Research Communications·Denis A MogilenkoAndrej P Perevozchikov
Oct 26, 2010·Journal of Lipid Research·John S MillarDaniel J Rader
Jun 15, 2014·Journal of Lipid Research·Matthew C Wheeler, Nicholas Gekakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.